-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Citius Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q4 2010 to Q3 2024.
- Citius Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 6.73M shares, a 11.2% increase year-over-year.
- Citius Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 6.73M shares, a 11.2% increase from 2023.
- Citius Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 6.05M shares, a 95.9% decline from 2022.
- Citius Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 146M shares, a 34.5% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)